2Baron JA, Gridley G, Weiderpass E, et al. Venous thromboembolism and cancer [J]. Lancet, 1998,351 (9109): 1077-1080.
3Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer [J]. Curr Opin Pulm Med, 2007,13(5):362-367.
4Kilic D, Akin S, Findikcioglu A, et al. Low-molecular-weight heparin for treatment of submassive pulmonary embolism after pneumonectomy [J]. Gen Thorac Cardiovasc Surg, 2007,55 (7) :287-289.
5Debourdeau P, Farge-Bancel D. Occult cancer and pulmonary embolism [J]. Rev Prat, 2007,57(7) :737-742.
6Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years [J]. BMJ, 1991,302(6778) : 709-711.
7Camez A, Dupuy E, Bellucci S, et al. Human platelet-tumor cell interactions vary with the tumor cell lines [J]. Invasion Metastasis, 1986,6(6) : 321-324.
8Naschitz JE, Yeshurun D, Lev LM. Thromboembolism in cancer. Changing trends [J]. Cancer, 1993,71 (4): 1384- 1390.
9Lee AY, Levien MN. Management of venous thromboembolism in cancer patients [J]. Oncology, 2000,14(3) :409-417.
10Khorana AA, Francis CW, Culakova E. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients [J]. Cancer, 2007,110(10):2339-2346.
